Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells

Charles L Stebbins, James P. Stice, C. Michael Hart, Fiona N. Mbai, Anne A Knowlton

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Endothelial dysfunction occurs in heart disease and may reduce functional capacity via attenuations in peripheral blood flow. Dietary decosahexaenoic acid (DHA) may improve this dysfunction, but the mechanism is unknown. This study determined if DHA enhances expression and activity of eNOS in cultured human coronary artery endothelial cells (HCAEC). HCAEC from 4 donors were treated with 5 nM, 50 nM, or 1 μM DHA for 7 days to model chronic DHA exposure. A trend for increased expression of endothelial nitric oxide synthase (eNOS) and phospho-eNOS was observed with 5 and 50 nM DHA. DHA also enhanced expression of 2 proteins instrumental in activation of eNOS: phospho-Akt (5 and 50 nM) and HSP90 (50 nM and 1 μM). Vascular endothelial growth factor-induced activation of Akt increased NOx in treated (50 nM DHA) versus untreated HCAEC (9.2 ± 1.0 vs 3.3 ± 1.1 μmol/μg protein/μL). Findings suggest that DHA enhances eNOS and Akt activity, augments HSP90 expression, and increases NO bioavailability in response to Akt kinase activation.

Original languageEnglish (US)
Pages (from-to)261-268
Number of pages8
JournalJournal of Cardiovascular Pharmacology and Therapeutics
Volume13
Issue number4
DOIs
StatePublished - Dec 2008

Fingerprint

Nitric Oxide Synthase Type III
Coronary Vessels
Endothelial Cells
Acids
Vascular Endothelial Growth Factor A
Biological Availability
Heart Diseases
Proteins
Phosphotransferases

Keywords

  • 3-nitrotyrosine
  • Akt kinase
  • Cell culture
  • HSP90
  • Phospho-Akt
  • Phospho-eNOS

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells. / Stebbins, Charles L; Stice, James P.; Hart, C. Michael; Mbai, Fiona N.; Knowlton, Anne A.

In: Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 13, No. 4, 12.2008, p. 261-268.

Research output: Contribution to journalArticle

Stebbins, Charles L ; Stice, James P. ; Hart, C. Michael ; Mbai, Fiona N. ; Knowlton, Anne A. / Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells. In: Journal of Cardiovascular Pharmacology and Therapeutics. 2008 ; Vol. 13, No. 4. pp. 261-268.
@article{2f9d4d3781df42d2afd56183160ed90d,
title = "Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells",
abstract = "Endothelial dysfunction occurs in heart disease and may reduce functional capacity via attenuations in peripheral blood flow. Dietary decosahexaenoic acid (DHA) may improve this dysfunction, but the mechanism is unknown. This study determined if DHA enhances expression and activity of eNOS in cultured human coronary artery endothelial cells (HCAEC). HCAEC from 4 donors were treated with 5 nM, 50 nM, or 1 μM DHA for 7 days to model chronic DHA exposure. A trend for increased expression of endothelial nitric oxide synthase (eNOS) and phospho-eNOS was observed with 5 and 50 nM DHA. DHA also enhanced expression of 2 proteins instrumental in activation of eNOS: phospho-Akt (5 and 50 nM) and HSP90 (50 nM and 1 μM). Vascular endothelial growth factor-induced activation of Akt increased NOx in treated (50 nM DHA) versus untreated HCAEC (9.2 ± 1.0 vs 3.3 ± 1.1 μmol/μg protein/μL). Findings suggest that DHA enhances eNOS and Akt activity, augments HSP90 expression, and increases NO bioavailability in response to Akt kinase activation.",
keywords = "3-nitrotyrosine, Akt kinase, Cell culture, HSP90, Phospho-Akt, Phospho-eNOS",
author = "Stebbins, {Charles L} and Stice, {James P.} and Hart, {C. Michael} and Mbai, {Fiona N.} and Knowlton, {Anne A}",
year = "2008",
month = "12",
doi = "10.1177/1074248408322470",
language = "English (US)",
volume = "13",
pages = "261--268",
journal = "Journal of Cardiovascular Pharmacology and Therapeutics",
issn = "1074-2484",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells

AU - Stebbins, Charles L

AU - Stice, James P.

AU - Hart, C. Michael

AU - Mbai, Fiona N.

AU - Knowlton, Anne A

PY - 2008/12

Y1 - 2008/12

N2 - Endothelial dysfunction occurs in heart disease and may reduce functional capacity via attenuations in peripheral blood flow. Dietary decosahexaenoic acid (DHA) may improve this dysfunction, but the mechanism is unknown. This study determined if DHA enhances expression and activity of eNOS in cultured human coronary artery endothelial cells (HCAEC). HCAEC from 4 donors were treated with 5 nM, 50 nM, or 1 μM DHA for 7 days to model chronic DHA exposure. A trend for increased expression of endothelial nitric oxide synthase (eNOS) and phospho-eNOS was observed with 5 and 50 nM DHA. DHA also enhanced expression of 2 proteins instrumental in activation of eNOS: phospho-Akt (5 and 50 nM) and HSP90 (50 nM and 1 μM). Vascular endothelial growth factor-induced activation of Akt increased NOx in treated (50 nM DHA) versus untreated HCAEC (9.2 ± 1.0 vs 3.3 ± 1.1 μmol/μg protein/μL). Findings suggest that DHA enhances eNOS and Akt activity, augments HSP90 expression, and increases NO bioavailability in response to Akt kinase activation.

AB - Endothelial dysfunction occurs in heart disease and may reduce functional capacity via attenuations in peripheral blood flow. Dietary decosahexaenoic acid (DHA) may improve this dysfunction, but the mechanism is unknown. This study determined if DHA enhances expression and activity of eNOS in cultured human coronary artery endothelial cells (HCAEC). HCAEC from 4 donors were treated with 5 nM, 50 nM, or 1 μM DHA for 7 days to model chronic DHA exposure. A trend for increased expression of endothelial nitric oxide synthase (eNOS) and phospho-eNOS was observed with 5 and 50 nM DHA. DHA also enhanced expression of 2 proteins instrumental in activation of eNOS: phospho-Akt (5 and 50 nM) and HSP90 (50 nM and 1 μM). Vascular endothelial growth factor-induced activation of Akt increased NOx in treated (50 nM DHA) versus untreated HCAEC (9.2 ± 1.0 vs 3.3 ± 1.1 μmol/μg protein/μL). Findings suggest that DHA enhances eNOS and Akt activity, augments HSP90 expression, and increases NO bioavailability in response to Akt kinase activation.

KW - 3-nitrotyrosine

KW - Akt kinase

KW - Cell culture

KW - HSP90

KW - Phospho-Akt

KW - Phospho-eNOS

UR - http://www.scopus.com/inward/record.url?scp=57649240564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649240564&partnerID=8YFLogxK

U2 - 10.1177/1074248408322470

DO - 10.1177/1074248408322470

M3 - Article

C2 - 18682551

AN - SCOPUS:57649240564

VL - 13

SP - 261

EP - 268

JO - Journal of Cardiovascular Pharmacology and Therapeutics

JF - Journal of Cardiovascular Pharmacology and Therapeutics

SN - 1074-2484

IS - 4

ER -